33 research outputs found
Conformation-Selective Analogues of Dasatinib Reveal Insight into Kinase Inhibitor Binding and Selectivity
In the kinase field, there are many
widely held tenets about conformation-selective
inhibitors that have yet to be validated using controlled experiments.
We have designed, synthesized, and characterized a series of kinase
inhibitor analogues of dasatinib, an FDA-approved kinase inhibitor
that binds the active conformation. This inhibitor series includes
two Type II inhibitors that bind the DFG-out inactive conformation
and two inhibitors that bind the αC-helix-out inactive conformation.
Using this series of compounds, we analyze the impact that conformation-selective
inhibitors have on target binding and kinome-wide selectivity